Tumours secreting big IGF-II are characterised by an increased total IGF-II:IGF-I ratio, hypoglycaemia with suppressed insulin and C-peptide and inappropriately low GH and β-OHB levels [62,63]. The gene discussed is GH1; the disease is neoplasm.